BELLRING BRANDS, INC. current report, 29 February 2024

BellRing Brands, Inc. Form 8-K Summary

Business Context and Reporting Period

BellRing Brands, Inc. filed a Form 8-K dated February 29, 2024 under Item 8.01 to report a change to its share repurchase authorization. The filing does not provide operating results for a fiscal reporting period.

Key Financial and Capital Allocation Information

  • The Board approved a new $300 million share repurchase authorization, effective March 11, 2024.
  • The new authorization replaces and cancels the existing $80 million authorization, which was approved May 3, 2023.
  • Approximately $79 million of common stock had been repurchased under the existing authorization as of February 29, 2024.
  • The new authorization remains available for two years beginning March 11, 2024.
  • Repurchases may be conducted through open-market or private transactions, forward or derivative transactions, accelerated repurchases, automatic purchase transactions, or other methods.
  • The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating performance metrics.

Material Changes, Outlook, and Risks

The principal material change is the increase in the authorized repurchase capacity from the remaining amount under the prior program to a new $300 million authorization. The authorization does not require the Company to repurchase any specific amount of shares and may be suspended or terminated at any time.

Management indicated that the timing and amount of repurchases will depend on liquidity, share price, market conditions, and legal requirements. The filing provides no earnings guidance or broader business outlook.

Important Facts for Investors to Verify

  • Whether the Company begins repurchases under the new authorization on or after March 11, 2024.
  • The actual amount and timing of future repurchases and the remaining authorization balance.
  • The effect of repurchases on shares outstanding, per-share results, and available liquidity.
  • Any subsequent disclosures regarding financing, liquidity, market conditions, or changes to the authorization.